Cited 27 times in
Effect-site concentration of remifentanil for laryngeal mask airway insertion during target-controlled infusion of propofol
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 남상범 | - |
dc.contributor.author | 이종화 | - |
dc.contributor.author | 장동진 | - |
dc.date.accessioned | 2015-04-24T16:56:46Z | - |
dc.date.available | 2015-04-24T16:56:46Z | - |
dc.date.issued | 2009 | - |
dc.identifier.issn | 0003-2409 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/104468 | - |
dc.description.abstract | The purpose of this study was to determine the effect-site concentration of remifentanil that would provide optimal conditions for successful laryngeal mask airway insertion during a target-controlled infusion (TCI) of propofol at 3.5 microg.ml(-1) without the use of neuromuscular blockade. Five minutes after propofol infusion, remifentanil was infused at a dose determined by a modified Dixon's up-and-down method. Five minutes after remifentanil infusion, the laryngeal mask was inserted. The effect-site concentration of remifentanil for successful laryngeal mask insertion in 50% of adults (EC(50)) was 3.04 (SD 0.49) ng.ml(-1) during a TCI of 3.5 microg.ml(-1) propofol without neuromuscular blockade. From the probit analysis, the EC(50) and EC(95) of remifentanil were 2.84 ng.ml(-1) (95% CI 2.09-3.57 ng.ml(-1)) and 3.79 ng.ml(-1) (95% CI 3.26-9.25 ng.ml(-1)), respectively. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 136~140 | - |
dc.relation.isPartOf | ANAESTHESIA | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Analgesics, Opioid/administration & dosage* | - |
dc.subject.MESH | Anesthetics, Intravenous/administration & dosage* | - |
dc.subject.MESH | Blood Pressure/drug effects | - |
dc.subject.MESH | Drug Administration Schedule | - |
dc.subject.MESH | Heart Rate/drug effects | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Infusions, Intravenous | - |
dc.subject.MESH | Laryngeal Masks* | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Piperidines/administration & dosage* | - |
dc.subject.MESH | Propofol/administration & dosage* | - |
dc.subject.MESH | Young Adult | - |
dc.title | Effect-site concentration of remifentanil for laryngeal mask airway insertion during target-controlled infusion of propofol | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Anesthesiology (마취통증의학) | - |
dc.contributor.googleauthor | M. K. Kim | - |
dc.contributor.googleauthor | J. W. Lee | - |
dc.contributor.googleauthor | D. J. Jang | - |
dc.contributor.googleauthor | O. Y. Shin | - |
dc.contributor.googleauthor | S. B. Nam | - |
dc.identifier.doi | 10.1111/j.1365-2044.2008.05707.x | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A01253 | - |
dc.contributor.localId | A03154 | - |
dc.contributor.localId | A03427 | - |
dc.relation.journalcode | J00128 | - |
dc.identifier.eissn | 1365-2044 | - |
dc.identifier.pmid | 19143689 | - |
dc.identifier.url | http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2044.2008.05707.x/abstract | - |
dc.contributor.alternativeName | Nam, Sang Beom | - |
dc.contributor.alternativeName | Lee, Jong Wha | - |
dc.contributor.alternativeName | Chang, Dong Jin | - |
dc.contributor.affiliatedAuthor | Nam, Sang Beom | - |
dc.contributor.affiliatedAuthor | Lee, Jong Wha | - |
dc.contributor.affiliatedAuthor | Chang, Dong Jin | - |
dc.citation.volume | 64 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 136 | - |
dc.citation.endPage | 140 | - |
dc.identifier.bibliographicCitation | ANAESTHESIA, Vol.64(2) : 136-140, 2009 | - |
dc.identifier.rimsid | 54142 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.